These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 27572416

  • 1. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY, Kang CI, Ko JH, Lee WJ, Seok HR, Park GE, Cho SY, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
    [Abstract] [Full Text] [Related]

  • 2. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH, Cho SY, Kang CI, Seok H, Huh K, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
    [Abstract] [Full Text] [Related]

  • 3. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
    Costa Pde O, Atta EH, Silva AR.
    J Pediatr (Rio J); 2015 Feb; 91(5):435-41. PubMed ID: 26057184
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients.
    Michalopoulos A, Falagas ME, Karatza DC, Alexandropoulou P, Papadakis E, Gregorakos L, Chalevelakis G, Pappas G.
    Am J Infect Control; 2011 Jun; 39(5):396-400. PubMed ID: 21035919
    [Abstract] [Full Text] [Related]

  • 9. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC, Wu PF, Lin YT, Wang FD.
    J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
    [Abstract] [Full Text] [Related]

  • 10. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
    Cho SY, Lee DG, Choi SM, Park C, Chun HS, Park YJ, Choi JK, Lee HJ, Park SH, Choi JH, Yoo JH.
    BMC Infect Dis; 2015 Feb 18; 15():69. PubMed ID: 25887489
    [Abstract] [Full Text] [Related]

  • 11. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A, Assawatheptawee K, Na-Udom A, Treebupachatsakul P, Wangteeraprasert A, Walsh TR, Niumsup PR.
    Antimicrob Agents Chemother; 2018 Aug 18; 62(8):. PubMed ID: 29891594
    [Abstract] [Full Text] [Related]

  • 12. Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
    Lee YT, Wang YC, Kuo SC, Chen CT, Liu CP, Liu YM, Chen TL, Yang YS.
    Antimicrob Agents Chemother; 2017 Sep 18; 61(9):. PubMed ID: 28674056
    [Abstract] [Full Text] [Related]

  • 13. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
    Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P.
    Clin Infect Dis; 2000 Sep 18; 31(3):705-11. PubMed ID: 11017819
    [Abstract] [Full Text] [Related]

  • 14. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM.
    J Microbiol Immunol Infect; 2016 Jun 18; 49(3):378-86. PubMed ID: 25081988
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases.
    Metan G, Demiraslan H, Kaynar LG, Zararsız G, Alp E, Eser B.
    Braz J Infect Dis; 2013 Jun 18; 17(2):143-9. PubMed ID: 23485438
    [Abstract] [Full Text] [Related]

  • 16. Stenotrophomonas maltophilia bacteraemia in Turkish children.
    Güriz H, Ciftçi E, Ayberkin E, Aysev D, Ince E, Arsan S, Yavuz G, Doğru U.
    Ann Trop Paediatr; 2008 Jun 18; 28(2):129-36. PubMed ID: 18510823
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia.
    Shin DH, Shin DY, Kang CK, Park S, Park J, Jun KI, Kim TS, Koh Y, Hong JS, Choe PG, Park WB, Kim NJ, Yoon SS, Kim I, Oh MD.
    BMC Infect Dis; 2020 Jun 09; 20(1):404. PubMed ID: 32517658
    [Abstract] [Full Text] [Related]

  • 18. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M.
    Diagn Microbiol Infect Dis; 2017 Apr 09; 87(4):359-364. PubMed ID: 28089138
    [Abstract] [Full Text] [Related]

  • 19. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH, Su TY, Ye JJ, Hsu PC, Kuo AJ, Chia JH, Lee MH.
    J Microbiol Immunol Infect; 2017 Oct 09; 50(5):677-683. PubMed ID: 26188977
    [Abstract] [Full Text] [Related]

  • 20. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
    Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A.
    Eur J Clin Microbiol Infect Dis; 2007 Jan 09; 26(1):13-20. PubMed ID: 17200840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.